Hi-Tech Pharmaceuticals Launched Pro IGF-1 Supplement

The company has initiated the second phase of its dietary supplement rollout in the United States.

Updated on Sept. 21, 2026 in Body Building

Macro view of a centrifuge tube with white liquid and whey protein powder on a laboratory table.
Hi-Tech Pharmaceuticals has officially launched the second phase of its Pro IGF-1 peptide supplement, which utilizes whey protein extraction technology. AI Illustration. Upload story photo >

Live Poll

Do you trust the safety and effectiveness of new, lab-derived performance supplements for your health?

Hi-Tech Pharmaceuticals has officially launched the second phase of its Pro IGF-1 Peptide supplement across the United States. The product features an IGF-1 hormone derived from whey protein.

Why it matters

The company aims to provide an accessible supply of a hormone that has historically been difficult and expensive to isolate. It claims that its proprietary delivery system offers superior stability and absorption for muscle growth compared to traditional growth hormone.

The supplement contains 175 µg of IGF-1 extracted from 100 g of whey protein, which consists of 70 amino acids in the peptide chain. The proprietary Cyclosome liposomal delivery system reportedly increases bioavailability by up to 1,500%.

The players

Hi-Tech Pharmaceuticals

This company is a manufacturer of dietary supplements that specializes in developing proprietary delivery systems for performance-enhancing compounds.

The details

Hi-Tech Pharmaceuticals utilizes a molecular biological technique to extract the hormone from whey protein. The product uses a Cyclosome coating that allows the peptide to dissolve in liquids and avoid typical digestive breakdown.

Timeline

  1. November 2018 marked the first phase of the Pro IGF-1 Peptide launch.

  2. September 21, 2026, served as the start date for the second phase of the product launch.

Season Trajectory

This release continues the expansion of specialized supplement technologies within the sports nutrition sector. The integration of advanced delivery mechanisms like Cyclosome reflects a broader trend toward enhancing the efficacy of traditionally unstable muscle-building compounds.

Consumers gain access to a form of IGF-1 engineered for improved liquid solubility and absorption. This product presents a new alternative for those seeking muscle growth support through hormone-based dietary supplementation.

The takeaway

This product highlights the industry shift toward using liposomal delivery systems to improve the bioavailability of performance compounds. Users should remain aware that these supplements aim to mimic biological hormonal pathways through isolated protein derivatives.

Further reading

Learn more about the latest developments in Body Building.

Source note: This article includes information reported by Nutritioninsight.

Live Poll

Do you trust the safety and effectiveness of new, lab-derived performance supplements for your health?